M. Arkin (1999) Ltd. insider trades: NeurogesX (NGSX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where M. Arkin (1999) Ltd. reports to the SEC
Open-market buys and sales
13 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 10, 2011 | NGSX | ↓ Sell | 163,468 | $2.08 | $340K | By Sphera Global Healthcare Master Fund | Aug 12, 2011 (2d) |
| Jun 27, 2011 | NGSX | ↓ Sell | 8,578 | $2.10 | $18K | By Sphera Global Healthcare Master Fund | Jun 28, 2011 (1d) |
| Jun 23, 2011 | NGSX | ↓ Sell | 50,000 | $2.09 | $105K | By Sphera Global Healthcare Master Fund | Jun 27, 2011 (4d) |
| Jun 16, 2011 | NGSX | ↓ Sell | 300,000 | $3.20 | $961K | By Sphera Global Healthcare Master Fund | Jun 20, 2011 (4d) |
| Mar 25, 2011 | NGSX | ↓ Sell | 152,600 | $4.03 | $616K | By Sphera Global Healthcare Master Fund | Mar 28, 2011 (3d) |
| Mar 23, 2011 | NGSX | ↓ Sell | 12,100 | $4.01 | $49K | By Sphera Global Healthcare Master Fund | Mar 25, 2011 (2d) |
| Jul 15, 2010 | OREX | ↓ Sell | 240,000 | $4.80 | $1.2M | Direct | Aug 16, 2010 (32d) |
| Jul 12, 2010 | OREX | ↓ Sell | 20,000 | $4.15 | $83K | By Sphera Global Healthcare Management L | Aug 16, 2010 (35d) |
| Feb 10, 2010 | NGSX | ↑ Buy | 122,803 | $7.23 | $887K | Direct | Jul 29, 2010 (169d) |
| Feb 10, 2010 | NGSX | ↑ Buy | 39,221 | $7.25 | $284K | By Sphera Global Healthcare Management L | Jul 29, 2010 (169d) |
| Jan 22, 2010 | NGSX | ↑ Buy | 1,111,013 | $7.89 | $8.8M | Direct | Jul 29, 2010 (188d) |
| Jan 7, 2010 | NGSX | ↑ Buy | 333,823 | $8.00 | $2.7M | By Sphera Global Healthcare Management L | Jul 29, 2010 (203d) |
| Jan 6, 2010 | OISI | ↑ Buy | 124,286 | $0.70 | $87K | Direct | Jan 8, 2010 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About M. Arkin (1999) Ltd.'s insider trades
M. Arkin (1999) Ltd. is an insider at NeurogesX (NGSX). Since Jan 6, 2010, it has reported 5 open-market purchases worth $12.7M and 8 sales worth $3.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NGSX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.